HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 269 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,429 | +805.5% | 159,761 | +712.0% | 0.02% | +433.3% |
| Q2 2023 | $710 | -5.5% | 19,674 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $751 | -32.9% | 19,674 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,119 | -99.9% | 19,674 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $778,000 | -10.2% | 19,674 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $866,000 | +10.3% | 19,674 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $785,000 | -11.9% | 19,674 | -11.2% | 0.00% | 0.0% |
| Q4 2021 | $891,000 | -1.1% | 22,149 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $901,000 | -10.4% | 22,149 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,006,000 | +9.0% | 22,149 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $923,000 | -2.4% | 22,149 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $946,000 | +34.8% | 22,149 | -17.1% | 0.01% | +25.0% |
| Q3 2020 | $702,000 | -2.0% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $716,000 | +48.9% | 26,722 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $481,000 | +1.5% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $474,000 | +14.5% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $414,000 | -9.8% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $459,000 | +6.7% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $430,000 | +10.0% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $391,000 | -19.5% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $486,000 | +7.8% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $451,000 | -13.8% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $523,000 | -7.8% | 26,722 | -4.6% | 0.00% | -25.0% |
| Q4 2017 | $567,000 | +16.7% | 27,999 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $486,000 | +35.4% | 27,999 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $359,000 | -1.1% | 27,999 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $363,000 | +31.0% | 27,999 | -0.0% | 0.00% | +50.0% |
| Q4 2016 | $277,000 | -18.0% | 28,013 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $338,000 | +39.7% | 28,013 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $242,000 | -8.7% | 28,013 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $265,000 | -44.8% | 28,013 | +1.0% | 0.00% | -50.0% |
| Q4 2015 | $480,000 | +165.2% | 27,723 | +106.2% | 0.00% | +100.0% |
| Q3 2015 | $181,000 | -40.5% | 13,444 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $304,000 | – | 13,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |